| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Lepu Medical Technology (Beijing) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.75 |
| 52 Week High | CN¥25.26 |
| 52 Week Low | CN¥11.60 |
| Beta | 0.052 |
| 1 Month Change | 3.15% |
| 3 Month Change | 13.37% |
| 1 Year Change | -38.34% |
| 3 Year Change | -54.04% |
| 5 Year Change | -40.72% |
| Change since IPO | -6.94% |
Recent News & Updates
Shareholder Returns
| 300003 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 6.8% | 6.0% | 4.2% |
| 1Y | -38.3% | -13.9% | -13.2% |
Return vs Industry: 300003 underperformed the CN Medical Equipment industry which returned -13.9% over the past year.
Return vs Market: 300003 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 300003 volatility | |
|---|---|
| 300003 Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300003 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300003's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 10,652 | Zhi Bin Zhang | www.lepumedical.com |
Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters and Angiocide peripheral cutting balloons; and cardiovascular products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, fractional flow reserves, and accessories.
Lepu Medical Technology (Beijing) Co., Ltd. Fundamentals Summary
| 300003 fundamental statistics | |
|---|---|
| Market cap | CN¥27.40b |
| Earnings (TTM) | CN¥1.14b |
| Revenue (TTM) | CN¥7.46b |
24.0x
P/E Ratio3.7x
P/S RatioIs 300003 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300003 income statement (TTM) | |
|---|---|
| Revenue | CN¥7.46b |
| Cost of Revenue | CN¥2.81b |
| Gross Profit | CN¥4.65b |
| Other Expenses | CN¥3.51b |
| Earnings | CN¥1.14b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 62.32% |
| Net Profit Margin | 15.31% |
| Debt/Equity Ratio | 26.5% |
How did 300003 perform over the long term?
See historical performance and comparison